| Literature DB >> 18817575 |
Shuyu Wu1, Eirini Chouliara, Lars Bogø Jensen, Anders Dalsgaard.
Abstract
BACKGROUND: Screening and enumeration of antimicrobial resistant Escherichia coli directly from samples is needed to identify emerging resistant clones and obtain quantitative data for risk assessment. Aim of this study was to evaluate the performance of 3M Petrifilm Select E. coli Count Plate (SEC plate) supplemented with antimicrobials to discriminate antimicrobial-resistant and non-resistant E. coli.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18817575 PMCID: PMC2564925 DOI: 10.1186/1751-0147-50-38
Source DB: PubMed Journal: Acta Vet Scand ISSN: 0044-605X Impact factor: 1.695
Concentrations of antimicrobial agents and interpretative breakpoint or cut-off values.
| Antimicrobial agents | Concentration ranges used in the three media (mg/L) | Quality control rangea for | CLSI clinical breakpoint (mg/L) | EUCAST epidemiological cut-offs (mg/L) | ||
| S | I | R | R | |||
| Ampicillin | 0.25–128 | 2–8 | ≤ 8 | 16 | ≥32 | > 8 |
| Cephalothin | 2–64 | 4–16 | ≤ 8 | 16 | ≥32 | > 32 |
| Chloramphenicol | 1–128 | 2–8 | ≤ 8 | 16 | ≥32 | > 16 |
| Gentamycin | 0.5–64 | 0.25–1 | ≤ 2 | 4 | ≥8 | > 2 |
| Streptomycin | 2–128 | 4–16b | ≤ 8 | 16 | ≥32 | > 16 |
| Cefotaxime | 0.06–128 | 0.03–0.12 | ≤ 8 | 16–32 | ≥64 | > 0.25 |
| Sulfamethoxazole | 8–1024 | 8–32 | ≤ 256 | _ | ≥ 512 | > 256 |
| Oxytetracycline | 0.25–256 | 0.5–2 | ≤ 4 | 8 | ≥16 | > 8 |
S, susceptible; I, intermediate; R, resistant.
a CLSI standard for agar dilution susceptibility testing[11].
b quality control range developed by the manufacturer Sensititre®
Figure 1Distribution of MIC (log. -.-.- Break point values as defined by CLSI; ---- EUCAST epidemiological cut-offs; when only one line is shown, breakpoint and cut-offs are identical; ........ Adjusted breakpoint value for oxytetracycline.
Agreements of MIC values obtained by susceptibility testing Escherichia coli strains on SEC and Mueller Hinton II agar plate media.
| Antimicrobial agent | No. of | Exact agreement | Within ± 1 dilution | Within ± 2 dilutions | Kappa valuea | |||
| No. | % | No. | % | No. | % | |||
| Ampicillin | 16 | 10 | 63 | 16 | 100 | 16 | 100 | 0.92 |
| Cephalothin | 15 | 4 | 17 | 11 | 73 | 14 | 93 | 0.67 |
| Chloramphenicol | 15 | 11 | 73 | 15 | 100 | 15 | 100 | 0.92 |
| Gentamicin | 14 | 7 | 50 | 14 | 100 | 14 | 100 | 0.93 |
| Streptomycin | 15 | 5 | 33 | 13 | 87 | 15 | 100 | 0.74 |
| Cefotaxime | 17 | 8 | 47 | 17 | 100 | 17 | 100 | 0.90 |
| Oxytetracycline | 22 | 0 | 0 | 3 | 14 | 11 | 50 | 0.48 |
| Sulphamethoxazole | 15 | 7 | 47 | 7 | 47 | 7 | 47 | 0.47 |
a The kappa value indicates the level of agreement between MIC values obtained by SEC and Mueller Hinton II agar plate media as follows: < 0.2, slight agreement; 0.2–0.4, fair agreement; 0.4–0.6, moderate agreement; 0.6–0.8, substantial agreement; > 0.8, almost perfect agreement.